Biotech - Press Releases

Date	Title	Company
22-Jul-2020	Collaboration with University College Dublin further expands its continuous flow platform	Almac Group
22-Jul-2020	Nouscom highlights cutting-edge science that led to the design of NOUS-209, a potential off-the-shelf neoantigen cancer vaccine for tumors with Microsatellite Instability	Nouscom
22-Jul-2020	RINVOQ™ (upadacitinib) Monotherapy Meets All Primary and Secondary Endpoints in Second Phase 3 Study for Atopic Dermatitis	AbbVie
22-Jul-2020	IRBM to collaborate with MSD to develop peptides against coronavirus	IRBM
22-Jul-2020	British Patient Capital commits $65m to SV Health Investors, to invest in life-changing biotechnology companies	British Patient Capital
22-Jul-2020	Phlexglobal and Arkivum join forces to enable Trial Master File data compliance over its entire extended lifecycle	Phlexglobal
22-Jul-2020	ZEAB Therapeutic engages Cresset Discovery Services to progress treatment for colorectal cancer	Cresset Discovery Services
22-Jul-2020	COVID-19 prompts increased focus on self-care, with Europeans taking their health more seriously to relieve pressure on healthcare systems	GSK Consumer Healthcare
22-Jul-2020	Biotech company raises £2.25m for new spinal treatments	Locate Bio
22-Jul-2020	UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S. healthcare investment firm	UCL Business
22-Jul-2020	UNION therapeutics announces acquisition of PDE4i compound class from LEO Pharma with oral lead candidate (orismilast) in Phase 2	UNION therapeutics A/S
22-Jul-2020	Ergomed H1 2020 Trading Update	Ergomed plc
22-Jul-2020	Algenex and Global DX Announce Positive Evaluation of Herdscreen® ASFV Antibody Test for African Swine Fever	Algenex SL
22-Jul-2020	Largest clinical study of its type shows Kaia back pain app outperforms standard-of-care treatment across all medical outcomes	Kaia Health
22-Jul-2020	Thermo Fisher Scientific Reports Second Quarter 2020 Results	Thermo Fisher Scientific
22-Jul-2020	United Therapeutics Corporation To Report Second Quarter 2020 Financial Results Before The Market Opens On Wednesday, July 29, 2020	United Therapeutics Corporation
22-Jul-2020	Arthex secures €4.25M from Invivo Ventures and Advent France Biotechnology	Andrew Lloyd Associates
22-Jul-2020	BioArctic's Partner Eisai to Present Update on the Development of BAN2401 at Alzheimer's Association International Conference 2020	BioArctic
21-Jul-2020	Coronavirus (COVID-19) Update: Daily Roundup	U.S. Food and Drug Administration
21-Jul-2020	Lysulin, Inc. Secures Patent for Nutritional Support for People with Diabetes and Prediabetes	Lysulin, Inc.